IMRT 2018

First page Table of contents Previous page 1146-1147 Next page Last page

Fase III trial HYPO-RT-PC

N: 1200 patients

78 (2Gy/fx) vs 42.7 Gy (7 x 6.1 Gy)

T1-T3 PSA < 20 Gleason <= 7

Preliminary results

SBRT No inferiority to standard

SBRT Low incidence of side-effects

Made with FlippingBook - professional solution for displaying marketing and sales documents online